STOCK TITAN

[144] MetLife, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

MetLife has filed a Form 144 notice for the proposed sale of 1,024 shares of common stock with an aggregate market value of $81,879.04. The sale is planned to be executed through Goldman Sachs on the NYSE, with an approximate sale date of June 27, 2025.

The securities to be sold were acquired in three separate purchases during 2013:

  • 31 shares from Deutsche Bank on January 31, 2013
  • 902 shares from Goldman Sachs on March 13, 2013
  • 91 shares from Goldman Sachs on May 15, 2013

Recent trading activity shows that related entities have sold 1,256 shares in the past three months, totaling approximately $99,076.70 in gross proceeds. The filing was made by the MetLife 401(k) Plan Trust, which maintains an affiliate discretionary manager relationship with the issuer. The company has 671,297,826 shares outstanding.

MetLife ha presentato un avviso Form 144 per la proposta vendita di 1.024 azioni ordinarie con un valore di mercato complessivo di 81.879,04 $. La vendita è prevista tramite Goldman Sachs alla NYSE, con data approssimativa di esecuzione il 27 giugno 2025.

Le azioni da vendere sono state acquistate in tre operazioni distinte nel 2013:

  • 31 azioni da Deutsche Bank il 31 gennaio 2013
  • 902 azioni da Goldman Sachs il 13 marzo 2013
  • 91 azioni da Goldman Sachs il 15 maggio 2013

L’attività recente di trading mostra che entità correlate hanno venduto 1.256 azioni negli ultimi tre mesi, per un ricavo lordo totale di circa 99.076,70 $. La segnalazione è stata effettuata dal MetLife 401(k) Plan Trust, che mantiene un rapporto di gestione discrezionale affiliata con l’emittente. La società ha 671.297.826 azioni in circolazione.

MetLife ha presentado un aviso Formulario 144 para la propuesta venta de 1.024 acciones ordinarias con un valor de mercado agregado de 81.879,04 $. La venta está planeada para ejecutarse a través de Goldman Sachs en la NYSE, con una fecha aproximada de venta el 27 de junio de 2025.

Los valores a vender fueron adquiridos en tres compras separadas durante 2013:

  • 31 acciones de Deutsche Bank el 31 de enero de 2013
  • 902 acciones de Goldman Sachs el 13 de marzo de 2013
  • 91 acciones de Goldman Sachs el 15 de mayo de 2013

La actividad reciente de negociación muestra que entidades relacionadas han vendido 1.256 acciones en los últimos tres meses, sumando aproximadamente 99.076,70 $ en ingresos brutos. La presentación fue realizada por el MetLife 401(k) Plan Trust, que mantiene una relación de gestor discrecional afiliado con el emisor. La compañía tiene 671.297.826 acciones en circulación.

MetLife는 총 시가 약 81,879.04달러 상당의 보통주 1,024주 매각을 위한 Form 144 신고를 제출했습니다. 이 매각은 뉴욕증권거래소(NYSE)에서 골드만 삭스를 통해 2025년 6월 27일경에 실행될 예정입니다.

매도할 증권은 2013년에 세 차례에 걸쳐 취득되었습니다:

  • 2013년 1월 31일 도이치뱅크에서 31주
  • 2013년 3월 13일 골드만 삭스에서 902주
  • 2013년 5월 15일 골드만 삭스에서 91주

최근 거래 내역에 따르면 관련 기관들이 지난 3개월간 1,256주를 매도하여 총 약 99,076.70달러의 총수익을 올렸습니다. 해당 신고는 발행사와 제휴된 재량 관리자를 두고 있는 MetLife 401(k) Plan Trust에 의해 이루어졌습니다. 회사의 발행 주식 수는 671,297,826주입니다.

MetLife a déposé un avis Formulaire 144 concernant la vente proposée de 1 024 actions ordinaires pour une valeur marchande totale de 81 879,04 $. La vente devrait être réalisée via Goldman Sachs à la NYSE, avec une date approximative de vente fixée au 27 juin 2025.

Les titres à vendre ont été acquis lors de trois achats distincts en 2013 :

  • 31 actions de Deutsche Bank le 31 janvier 2013
  • 902 actions de Goldman Sachs le 13 mars 2013
  • 91 actions de Goldman Sachs le 15 mai 2013

Les opérations récentes indiquent que des entités liées ont vendu 1 256 actions au cours des trois derniers mois, générant environ 99 076,70 $ de produit brut. Le dépôt a été effectué par le MetLife 401(k) Plan Trust, qui entretient une relation de gestion discrétionnaire affiliée avec l’émetteur. La société compte 671 297 826 actions en circulation.

MetLife hat eine Form 144-Meldung für den geplanten Verkauf von 1.024 Aktien Stammaktien mit einem Gesamtmarktwert von 81.879,04 $ eingereicht. Der Verkauf soll über Goldman Sachs an der NYSE erfolgen, mit einem voraussichtlichen Verkaufsdatum am 27. Juni 2025.

Die zu verkaufenden Wertpapiere wurden in drei separaten Käufen im Jahr 2013 erworben:

  • 31 Aktien von der Deutschen Bank am 31. Januar 2013
  • 902 Aktien von Goldman Sachs am 13. März 2013
  • 91 Aktien von Goldman Sachs am 15. Mai 2013

Die jüngsten Handelsaktivitäten zeigen, dass verbundene Unternehmen in den letzten drei Monaten 1.256 Aktien verkauft haben, mit einem Bruttoerlös von etwa 99.076,70 $. Die Meldung wurde vom MetLife 401(k) Plan Trust eingereicht, der eine verbundene diskretionäre Managerbeziehung zum Emittenten unterhält. Das Unternehmen hat 671.297.826 ausstehende Aktien.

Positive
  • None.
Negative
  • None.

MetLife ha presentato un avviso Form 144 per la proposta vendita di 1.024 azioni ordinarie con un valore di mercato complessivo di 81.879,04 $. La vendita è prevista tramite Goldman Sachs alla NYSE, con data approssimativa di esecuzione il 27 giugno 2025.

Le azioni da vendere sono state acquistate in tre operazioni distinte nel 2013:

  • 31 azioni da Deutsche Bank il 31 gennaio 2013
  • 902 azioni da Goldman Sachs il 13 marzo 2013
  • 91 azioni da Goldman Sachs il 15 maggio 2013

L’attività recente di trading mostra che entità correlate hanno venduto 1.256 azioni negli ultimi tre mesi, per un ricavo lordo totale di circa 99.076,70 $. La segnalazione è stata effettuata dal MetLife 401(k) Plan Trust, che mantiene un rapporto di gestione discrezionale affiliata con l’emittente. La società ha 671.297.826 azioni in circolazione.

MetLife ha presentado un aviso Formulario 144 para la propuesta venta de 1.024 acciones ordinarias con un valor de mercado agregado de 81.879,04 $. La venta está planeada para ejecutarse a través de Goldman Sachs en la NYSE, con una fecha aproximada de venta el 27 de junio de 2025.

Los valores a vender fueron adquiridos en tres compras separadas durante 2013:

  • 31 acciones de Deutsche Bank el 31 de enero de 2013
  • 902 acciones de Goldman Sachs el 13 de marzo de 2013
  • 91 acciones de Goldman Sachs el 15 de mayo de 2013

La actividad reciente de negociación muestra que entidades relacionadas han vendido 1.256 acciones en los últimos tres meses, sumando aproximadamente 99.076,70 $ en ingresos brutos. La presentación fue realizada por el MetLife 401(k) Plan Trust, que mantiene una relación de gestor discrecional afiliado con el emisor. La compañía tiene 671.297.826 acciones en circulación.

MetLife는 총 시가 약 81,879.04달러 상당의 보통주 1,024주 매각을 위한 Form 144 신고를 제출했습니다. 이 매각은 뉴욕증권거래소(NYSE)에서 골드만 삭스를 통해 2025년 6월 27일경에 실행될 예정입니다.

매도할 증권은 2013년에 세 차례에 걸쳐 취득되었습니다:

  • 2013년 1월 31일 도이치뱅크에서 31주
  • 2013년 3월 13일 골드만 삭스에서 902주
  • 2013년 5월 15일 골드만 삭스에서 91주

최근 거래 내역에 따르면 관련 기관들이 지난 3개월간 1,256주를 매도하여 총 약 99,076.70달러의 총수익을 올렸습니다. 해당 신고는 발행사와 제휴된 재량 관리자를 두고 있는 MetLife 401(k) Plan Trust에 의해 이루어졌습니다. 회사의 발행 주식 수는 671,297,826주입니다.

MetLife a déposé un avis Formulaire 144 concernant la vente proposée de 1 024 actions ordinaires pour une valeur marchande totale de 81 879,04 $. La vente devrait être réalisée via Goldman Sachs à la NYSE, avec une date approximative de vente fixée au 27 juin 2025.

Les titres à vendre ont été acquis lors de trois achats distincts en 2013 :

  • 31 actions de Deutsche Bank le 31 janvier 2013
  • 902 actions de Goldman Sachs le 13 mars 2013
  • 91 actions de Goldman Sachs le 15 mai 2013

Les opérations récentes indiquent que des entités liées ont vendu 1 256 actions au cours des trois derniers mois, générant environ 99 076,70 $ de produit brut. Le dépôt a été effectué par le MetLife 401(k) Plan Trust, qui entretient une relation de gestion discrétionnaire affiliée avec l’émetteur. La société compte 671 297 826 actions en circulation.

MetLife hat eine Form 144-Meldung für den geplanten Verkauf von 1.024 Aktien Stammaktien mit einem Gesamtmarktwert von 81.879,04 $ eingereicht. Der Verkauf soll über Goldman Sachs an der NYSE erfolgen, mit einem voraussichtlichen Verkaufsdatum am 27. Juni 2025.

Die zu verkaufenden Wertpapiere wurden in drei separaten Käufen im Jahr 2013 erworben:

  • 31 Aktien von der Deutschen Bank am 31. Januar 2013
  • 902 Aktien von Goldman Sachs am 13. März 2013
  • 91 Aktien von Goldman Sachs am 15. Mai 2013

Die jüngsten Handelsaktivitäten zeigen, dass verbundene Unternehmen in den letzten drei Monaten 1.256 Aktien verkauft haben, mit einem Bruttoerlös von etwa 99.076,70 $. Die Meldung wurde vom MetLife 401(k) Plan Trust eingereicht, der eine verbundene diskretionäre Managerbeziehung zum Emittenten unterhält. Das Unternehmen hat 671.297.826 ausstehende Aktien.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many MET shares are being sold according to the June 2025 Form 144 filing?

According to the Form 144 filing, 1,024 shares of MetLife (MET) common stock are proposed to be sold through Goldman Sachs, with an aggregate market value of $81,879.04. The sale is expected to take place on the NYSE around June 27, 2025.

Who is selling MET shares in this Form 144 filing?

The MetLife 401(k) Plan Trust is selling the shares, acting as an affiliate discretionary manager. The filing was signed by Mirsad Usejnoski and the shares will be sold through Goldman Sachs at 200 West Street, New York.

What recent MET stock sales were disclosed in the three months prior to this Form 144?

In the three months prior to this filing, there were several sales of MET stock: 221 shares by Separate Account II on 6/13/2025, and on 6/20/2025: 547 shares by MetLife 401k Plan Trust, 360 shares by Separate Account SPI, 101 shares by Separate Account II, and 27 shares by Separate Account 149, totaling 1,256 shares.

When were the MET shares being sold originally acquired?

The shares being sold were acquired in three separate purchases in early 2013: 31 shares from Deutsche Bank on January 31, 2013, 902 shares from Goldman Sachs on March 13, 2013, and 91 shares from Goldman Sachs on May 15, 2013. All purchases were made with cash payment.

What is the total number of MET shares outstanding as of June 2025?

According to the Form 144 filing, MetLife (MET) had 671,297,826 shares outstanding at the time of the filing in June 2025.
MetLife

NYSE:MET

MET Rankings

MET Latest News

MET Latest SEC Filings

MET Stock Data

53.17B
560.14M
16.51%
76.26%
1.08%
Insurance - Life
Life Insurance
Link
United States
NEW YORK